Avenue Therapeutics Inc. (ATXI)
NASDAQ: ATXI
· Real-Time Price · USD
0.23
0.00 (0.00%)
At close: May 01, 2025, 3:05 PM
0.23
0.00%
After-hours: May 01, 2025, 03:05 PM EDT
0.00% (1D)
| Bid | 0.23 |
| Market Cap | 724.75K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -16.15M |
| EPS (ttm) | -15.79 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.12 |
| Analyst | n/a |
| Ask | 0.25 |
| Volume | 2,001 |
| Avg. Volume (20D) | 66,657 |
| Open | 0.23 |
| Previous Close | 0.23 |
| Day's Range | 0.23 - 0.23 |
| 52-Week Range | 0.23 - 5.97 |
| Beta | 0.10 |
About ATXI
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York....
Industry Biotechnology
Sector Healthcare
IPO Date Jun 27, 2017
Employees 2
Stock Exchange NASDAQ
Ticker Symbol ATXI
Website https://www.avenuetx.com
